Here's what it would take to turn a $10,000 investment in this high-flying healthcare stock into a cool $1 million.
What happened Shares of Livongo Health (NASDAQ: LVGO) were jumping 11.8% higher as of 3:05 p.m. EDT on Tuesday. The surge appeared to be the result of Jim Cramer highlighting the stock on CNBC's Mad Money on Monday.
Microsoft is helping to lead the Dow Jones Industrial Average to a bullish second quarter so far. These growth stocks are also breaking out.
At the same time, the economy has gotten whacked by the COVID-19 pandemic, and most major economic indicators point to a deep recession. Despite the challenges and the uncertainty for investors in the current market environment, there are still some good deals for high growth stocks that should do well regardless of what happens with the COVID-19 pandemic. Keep reading to see why Roku (NASDAQ: ROKU), JD.com (NASDAQ: JD), and Livongo Health (NASDAQ: LVGO) should be on your buy list.
As the market crashed into bear territory this spring, Livongo Health (NASDAQ: LVGO) was on its way to a record high. And that's where the stock stands at the moment, up 115% this year. After this kind of performance, can we expect more from Livongo? Let's have a look.
The stock rose sharply on Thursday after the virtual healthcare specialist beat estimates and unexpectedly achieved profitability in the first quarter.
MOUNTAIN VIEW, Calif., May 26, 2020 -- Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better.
A bear market is a great time for opportunistic long-term investors to put their money to work in fast-growing companies.
When it comes to investing in small up-and-coming businesses, picking just one or two usually won't suffice. For my latest batch of purchases in the wake of the coronavirus-fueled economic crisis, I scooped up shares of Livongo Health (NASDAQ: LVGO), Cloudflare (NYSE: NET), Fastly (NYSE: FSLY), Repay Holdings (NASDAQ: RPAY), and VectoIQ Acquisition (NASDAQ: VTIQ) (set to become Nikola). A few years ago, I purchased a tiny but up-and-coming stock called Teladoc Health, thinking that medical care delivered via an internet connection had a bright future.
Livongo (LVGO) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Although we've rebounded quite a bit off of the March lows, the U.S. economy and labor market remain shells of where they were just three months ago, with job losses surpassing 30 million and second-quarter gross domestic product expected to come in at a year-on-year decline of more than 30%, according to many Wall Street estimates. While putting a bear market into the rearview mirror isn't going to happen overnight, this data conclusively shows that buying stocks during major stock market declines is always a smart move. With most brokerages removing the commissions associated with stock purchases and sales on major U.S. exchanges, the barriers to invest in the market have been torn down.
Is (LVGO) Outperforming Other Medical Stocks This Year?
Livongo (LVGO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
These healthcare stocks are already dominant, and it should remain that way for a long time to come.
These industries, and the companies within them, are capable of a sustained double-digit growth rate.
Investors who aren't already billionaires can still make plenty of money buying these attractive stocks.
Shares of Livongo Health (NASDAQ: LVGO), maker of remote patient-monitoring solutions, soared 12% to an all-time high Thursday after the company reported first-quarter results. Revenue grew 115% to $68.
The coronavirus pandemic has helped digital health surge like never before. With virtual visits increasing on a daily basis, we have five stocks that are set to gain.
These two companies are performing well amid the market downturn, and they could continue to thrive long after it ends.
Livongo Health's financial fortunes should keep on getting better. Keith Speights owns shares of Livongo Health Inc. The Motley Fool owns shares of and recommends Livongo Health Inc. The Motley Fool has a disclosure policy.